Walsh Mark A, Stuart Alan G, Schlecht Helene B, James Andrew F, Hancox Jules C, Newbury-Ecob Ruth A
Bristol Royal Hospital for Children, Bristol, UK.
Bristol Heart Institute, Bristol, UK.
Pacing Clin Electrophysiol. 2016 May;39(5):497-501. doi: 10.1111/pace.12813. Epub 2016 Mar 2.
We present the case of two siblings who both presented with an out-of-hospital cardiac arrest at 2 years of age. Both siblings underwent internal cardiac defibrillator implantation and both had recurrent episodes of ventricular fibrillation (VF). A compound heterozygous mutation in the triadin gene was discovered; one of these mutations has been described previously in the homozygous state, and the other one is unreported. The combination of these mutations has resulted in a particularly arrhythmogenic phenotype, with cardiac arrest occurring at a very young age and recurrent episodes of VF despite β-blockade. Flecainide seems to have been very effective in preventing clinical arrhythmias for this particular mutation.
我们报告了一对同胞兄妹的病例,他们均在2岁时出现院外心脏骤停。这对兄妹均接受了体内植入式心脏除颤器治疗,且都有室颤(VF)反复发作的情况。在三联蛋白基因中发现了复合杂合突变;其中一种突变先前已在纯合状态下被描述过,另一种则未曾报道。这些突变的组合导致了一种特别易致心律失常的表型,尽管使用了β受体阻滞剂,仍在非常年幼时就发生心脏骤停且室颤反复发作。氟卡尼似乎对预防这种特定突变所致的临床心律失常非常有效。